Global 'Essential Principles' Of Safety And Performance: IMDRF Sheds New Light
Executive Summary
An updated guidance document from the International Medical Device Regulators Forum seeks to support global convergence on the guidance documents and standards that companies can use to meet "essential principles" of safety and performance for medical devices and IVDs.
You may also be interested in...
Global Medtech Guidance Tracker: January 2018
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twelve new guidance documents were posted to the tracker since its last update.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.